176.22
price down icon1.25%   -1.88
 
loading
Precedente Chiudi:
$178.10
Aprire:
$179.98
Volume 24 ore:
14,098
Relative Volume:
0.07
Capitalizzazione di mercato:
$5.12B
Reddito:
$241.52M
Utile/perdita netta:
$52.37M
Rapporto P/E:
-119.88
EPS:
-1.47
Flusso di cassa netto:
$58.06M
1 W Prestazione:
-0.85%
1M Prestazione:
-1.73%
6M Prestazione:
+5.42%
1 anno Prestazione:
+73.71%
Intervallo 1D:
Value
$175.09
$179.98
Intervallo di 1 settimana:
Value
$168.88
$181.69
Portata 52W:
Value
$99.00
$219.34

Krystal Biotech Inc Stock (KRYS) Company Profile

Name
Nome
Krystal Biotech Inc
Name
Telefono
(412) 586-5830
Name
Indirizzo
2100 WHARTON STREET, PITTSBURGH, PA
Name
Dipendente
229
Name
Cinguettio
@KrystalBiotech
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
KRYS's Discussions on Twitter

Confronta KRYS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
KRYS 176.22 5.12B 241.52M 52.37M 58.06M -1.47
VRTX 447.17 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.51 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 589.70 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 250.25 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.14 24.49B 3.30B -501.07M 1.03B 11.54

Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-11-20 Iniziato Goldman Buy
2023-10-24 Iniziato Cantor Fitzgerald Overweight
2023-10-12 Iniziato Citigroup Buy
2023-09-07 Iniziato Berenberg Buy
2023-04-18 Iniziato Stifel Buy
2023-02-28 Aggiornamento Goldman Neutral → Buy
2022-08-25 Downgrade Goldman Buy → Neutral
2022-01-18 Iniziato BofA Securities Buy
2021-07-20 Aggiornamento Goldman Neutral → Buy
2020-09-18 Iniziato B. Riley FBR Buy
2020-06-04 Iniziato Evercore ISI Outperform
2019-09-24 Iniziato Goldman Neutral
2019-08-06 Reiterato H.C. Wainwright Buy
2019-06-24 Reiterato Chardan Capital Markets Buy
2019-06-24 Reiterato H.C. Wainwright Buy
2019-05-30 Iniziato Guggenheim Buy
2018-09-11 Iniziato Cantor Fitzgerald Overweight
Mostra tutto

Krystal Biotech Inc Borsa (KRYS) Ultime notizie

pulisher
05:37 AM

Jennison Associates LLC Sells 110,333 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

05:37 AM
pulisher
Nov 20, 2024

Segall Bryant & Hamill LLC Boosts Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

First Turn Management LLC Has $12.37 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Victory Capital Management Inc. - MarketBeat

Nov 19, 2024
pulisher
Nov 15, 2024

Redmile Group, LLC Adjusts Stake in Krystal Biotech Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Principal Financial Group Inc. Sells 3,743 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

(KRYS) Proactive Strategies - Stock Traders Daily

Nov 13, 2024
pulisher
Nov 12, 2024

FMR LLC's Strategic Acquisition of Krystal Biotech Inc Shares - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

High Growth Tech Stocks Featuring Three Prominent US Companies - Simply Wall St

Nov 12, 2024
pulisher
Nov 12, 2024

Krystal Biotech Inc (KRYS) Quarterly 10-Q Report - Quartzy

Nov 12, 2024
pulisher
Nov 12, 2024

Krystal Biotech to Present at Stifel 2024 Healthcare Conference - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Raised by TimesSquare Capital Management LLC - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Janney Montgomery Scott LLC Buys 5,415 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Chardan Capital Predicts Lower Earnings for Krystal Biotech - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

Q2 EPS Estimates for Krystal Biotech Raised by William Blair - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

HC Wainwright Predicts Reduced Earnings for Krystal Biotech - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

HC Wainwright Forecasts Higher Earnings for Krystal Biotech - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Krystal Biotech FY2024 EPS Forecast Raised by William Blair - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $206.00 at Citigroup - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Krystal Biotech (NASDAQ:KRYS) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Krystal Biotech (NASDAQ:KRYS) Posts Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 05, 2024
pulisher
Nov 05, 2024

Krystal Biotech Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Nov 05, 2024
pulisher
Nov 05, 2024

Krystal stock gains modest boost from Citi, but compliance risks linger - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Krystal Biotech, Inc. (KRYS) Beats Q3 Earnings and Revenue Estimates - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Nov 05, 2024
pulisher
Nov 05, 2024

Krystal Biotech Faces Challenges in Scaling VYJUVEK Production Amid Regulatory Hurdles - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

Earnings call: Krystal Biotech reports robust Q3 2024 results By Investing.com - Investing.com Nigeria

Nov 05, 2024
pulisher
Nov 04, 2024

Krystal Biotech Reports Strong Q3 2024 Performance - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

Earnings call: Krystal Biotech reports robust Q3 2024 results - Investing.com India

Nov 04, 2024
pulisher
Nov 04, 2024

Krystal Biotech (NASDAQ:KRYS) Shares Gap DownHere's Why - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Krystal Biotech earnings missed by $0.08, revenue topped estimates - Investing.com UK

Nov 04, 2024
pulisher
Nov 04, 2024

Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

Krystal Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 04, 2024
pulisher
Nov 02, 2024

Are Options Traders Betting on a Big Move in Krystal Biotech (KRYS) Stock? - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Where are the Opportunities in (KRYS) - Stock Traders Daily

Nov 02, 2024
pulisher
Nov 01, 2024

Earnings To Watch: Krystal Biotech Inc (KRYS) Reports Q3 2024 Re - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings To Watch: Krystal Biotech Inc (KRYS) Reports Q3 2024 Results - Yahoo Finance

Nov 01, 2024
pulisher
Oct 29, 2024

Krystal Biotech (KRYS) Set to Announce Quarterly Earnings on Monday - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth - MSN

Oct 28, 2024
pulisher
Oct 28, 2024

Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024 - The Manila Times

Oct 28, 2024
pulisher
Oct 25, 2024

Hennion & Walsh Asset Management Inc. Cuts Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

Oct 25, 2024

Krystal Biotech Inc Azioni (KRYS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):